Association between plasma D-dimer levels and disease severity in chronic spontaneous urticaria

Pham Thi Thao, Nguyen Van Thuong, Pham Thi Minh Phuong, Vu Nguyet Minh, Le Huu Doanh, Le Huyen My, Nguyen Quynh Anh

Main Article Content

Abstract

A cross-sectional study was conducted in 146 patients with chronic spontaneous urticaria (CSU) and 30 healthy adults to determine the association between plasma D-dimer levels and disease severity as well as related factors. The results showed that the median (IQR) plasma D-dimer level in CSU patients was 546.5 (291 - 1353) ng/ml, which was significantly higher than the control group at 270 (270 - 270) ng/ml (p < 0.001). Plasma D-dimer levels were positively correlated with the UAS7 score, with a Spearman correlation coefficient of 0.46 (p < 0.001). ROC analysis revealed the cut-off value of D-dimer of 633 ng/ml for differentiating severe from non-severe CSU. This differential level was strengthened through both univariate and multivariate logistic regression analyses. In addition, D-dimer levels were associated with age, CRP level, and a positive autologous serum skin test. These findings suggest that plasma D-dimer may be a potential biomarker for predicting disease severity in patients with CSU.

Article Details

References

1. Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734-766. doi:10.1111/all.15090
2. Church MK, Kolkhir P, Metz M, et al. The role and relevance of mast cells in urticaria. Immunol Rev. 2018;282(1):232-247. doi:10.1111/imr.12632
3. Yanase Y, Takahagi S, Hide M. Chronic spontaneous urticaria and the extrinsic coagulation system. Allergology International. 2018;67(2):191-194. doi:10.1016/j.alit.2017.09.003
4. Farres MN, Refaat M, Melek NA, et al. Activation of coagulation in chronic urticaria in relation to disease severity and activity. Allergologia et Immunopathologia. 2015;43(2):162-167. doi:10.1016/j.aller.2014 .04.002
5. Grzanka R, Damasiewicz-Bodzek A, Kasperska-Zajac A. Interplay between acute phase response and coagulation/fibrinolysis in chronic spontaneous urticaria. Allergy Asthma Clin Immunol. 2018;14:27. doi:10.1186/s13223-018-0255-8
6. Beyaz Ş, Belkaya S, Öztop N. Circulating Pentraxin-3 and its association with C-reactive protein levels and disease activity in patients with chronic spontaneous urticaria. Allergol Immunopathol (Madr). 2023;51(4):87-93. doi:10.15586/aei.v51i4.894
7. Di Pino M, Ruberto MF, Costanzo G, et al. Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by Omalizumab. Clin Exp Med. 2023;23(2):495-502. doi:10.1007/s10238-022-00838-9
8. Dabas G, Thakur V, Bishnoi A, et al. Causal Relationship between D-Dimers and Disease Status in Chronic Spontaneous Urticaria and Adjuvant Effect of Oral Tranexamic Acid. Indian Dermatol Online J. 2021;12(5):726-730. doi:10.4103/idoj.IDOJ_106_21
9. Criado RF, Bensi CG, Criado PR, et al. Evaluation of serum levels of C-reactive protein, D-Dimer and Autologous Serum Skin Test in patients with Chronic Spontaneous Urticaria in a Brazilian tertiary center : a cross-sectional study. An Bras Dermatol. 2021;96(2):148-154. doi:10.1016/j.abd.2020.07.006
10. Chintada D, Vudayana K, Chaduvula J, et al. Clinicoepidemiological Profile of Patients with Chronic Urticaria and its Association with D-dimer Levels at a Tertiary Care Centre: A Prospective Cohort Study. JCDR. Published online 2023. doi:10.7860/JCDR/2023/66909.18780
11. Relvas M, Silva J, Matos AL, et al. Concomitant evaluation of D-dimer and C-reactive protein in chronic spontaneous urticaria may show divergent values. Eur Ann Allergy Clin Immunol. 2024;56(2):89-92. doi:10.23822/EurAnnACI.1764-1489.259
12. Plavsic A, Tomic-Spiric V, Arandjelovic S, et al. Biomarkers of disease activity in patients with chronicspontaneous urticaria. pdia. 2021;38(6):1017-1022. doi:10.5114/ada.2021.112276
13. Kitao R, Oda Y, Washio K, et al. Lower efficacy of omalizumab in older adults with chronic spontaneous urticaria. J Dermatol. 2022;49(7):729-731. doi:10.1111/1346-8138.16370
14. Kasperska-Zajac A, Grzanka A, Misiolek M, et al. Pentraxin-3 as a local inflammatory marker in chronic spontaneous urticaria. Cytokine. 2015;76(2):566-568. doi:10.1016/j.cyto.2015.04.016
15. Kolkhir P, Altrichter S, Hawro T, et al. C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria. Allergy. 2018;73(4):940-948. doi:10.1111/all.13352